Clinical Trial Update: AZD1386 Japanese Multiple Ascending Dosing Study [Phase 1]

View source ↗

Summary

AZD1386 Phase 1 multiple ascending dose trial in Japanese participants for chronic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• AZD1386 (Capsaicin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Pain | Phase 1 | Status: COMPLETED